Publications by authors named "P Gronesova"

Background: Circulating tumor cells (CTCs) contribute to the metastatic cascade and represent an independent survival predictor in breast cancer (BC) patients. Vitamin D has pleiotropic effects, and its low concentrations are associated with breast cancer and metastasis. The aim of this study was to assess plasma vitamin D in primary BC patients in relation to CTCs.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how the tumor microenvironment and the inflammatory response affect cancer progression, specifically in germ cell tumors (GCTs).
  • It focuses on the systemic immune-inflammation index (SII) as a prognostic marker in chemotherapy-naïve GCT patients, analyzing immune cell changes before treatment.
  • Findings reveal that higher SII levels correlate with increased neutrophils and decreased lymphocytes, particularly T-cell subpopulations, suggesting a link between cancer and immune suppression.
View Article and Find Full Text PDF

The pattern of immune cell distribution in testicular germ cell tumors (GCT) significantly differs from the immune environment in normal testicular tissues. The present study aimed to evaluate the role of different leukocyte subpopulation in GCTs. A cohort of 84 chemotherapy-naïve GCT patients was analyzed.

View Article and Find Full Text PDF

Chemoresistance of germ cell tumors (GCTs) represents an intensively studied property of GCTs that is the result of a complicated multifactorial process. One of the driving factors in this process is the tumor microenvironment (TME). Intensive crosstalk between the DNA damage/DNA repair pathways and the TME has already been reported.

View Article and Find Full Text PDF

Programmed death ligand 1 (PD-L1) overexpression has been associated with poor clinical outcomes in several human cancers whose increased malignant behaviour might be related to PD-L1 mediated systemic immunological tolerance. This study aims to verify if circulating cytokines may serve as a proxy for non-invasive identification of sensitive prognostic biomarkers reflecting tumour and its microenvironment. Immunohistochemistry was used to measure PD-L1 expression in tumour tissue sections of 148 chemonaïve breast cancer (BC) patients.

View Article and Find Full Text PDF